China Digest: Nourse bags over $30m; KIP backs MaxHealth Biotechnology

Pet nutrition product supplier Nourse and Chengdu MaxHealth Biotechnology have secured funding.   

Temasek-backed Vertex backs Nourse’s Series B++

Chinese pet nutrition product supplier Nourse has completed its Series B++ round of financing raising over 200 million yuan ($30 million) from existing investors such as Vertex Ventures China, per a company statement on Wednesday. 

The company has raised a total of 900 million yuan ($139 million) in three tranches of its Series B round. Its Series B tranches have been backed by investors including Hony Capital, Meridian Capital China, Tencent Investment, Cathay Capital and Highlight Capital. 

Founded by Shaohua Lv in 2004, Nourse produces special dietary supplements for dogs and cats. It has built competitive online channels on Tmall and JD.com for its pipeline of 21 products.

KIP backs MaxHealth Biotechnology

Chengdu MaxHealth Biotechnology LLC, a clinical-stage firm focused on vaccine R&D, has received ‘tens of millions of US dollars’ in its Series A round of financing, according to a company statement on Wednesday. 

Existing investors – Korea Investment Partners (KIP), Hillhouse Capital’s venture unit GL Ventures and Sherpa Healthcare Partners – participated in the latest round. The three investors had partnered for  MaxHealth’s Pre-A round as well. 

MaxHealth, founded by Dr. Dexiang Chen in 2017, has rolled out 10 vaccine pipelines that cater to treatment areas targeting infectious diseases, allergies and cancers. 

Singapore Reporter/s

In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digitally savvy and ready to experiment with new forms of storytelling. Most importantly, we are looking for hard-hitting reporters who work well in a team. Collaboration and collegiality are a must.

Following vacancies can be applied for (only in Singapore).

Following vacancies can be applied for (only in Singapore).   

  • A reporter to track companies/startups that have raised private capital, and have the potential to become unicorns. SEA currently has over 40 companies with a valuation of over $100 million and under $1 billion.
  • A reporter who can get behind the scenes and reveal how funding rounds are put together, or why they’ve failed to materialise. She/he in this role will largely focus on long-format stories. 
  • A journalist to track special situations funds, distressed debt and private credit (from the PE angle) across Asia.

Singapore Reporter/s

In Singapore, we are looking to double our reporting team by this year-end to comprehensively cover the fast-moving world of funded startups and VC, PE & M&A deals. We want reporters who can tell our readers what is really happening in these sectors and why it matters to markets, companies and consumers. The ability to write precisely and urgently is crucial for these roles. Ideal candidates must have to ability to work in a collaborative, dynamic, and fast-changing environment. We want our new hires to be digitally savvy and ready to experiment with new forms of storytelling. Most importantly, we are looking for hard-hitting reporters who work well in a team. Collaboration and collegiality are a must.

Following vacancies can be applied for (only in Singapore).

Following vacancies can be applied for (only in Singapore).   

  • A reporter to track companies/startups that have raised private capital, and have the potential to become unicorns. SEA currently has over 40 companies with a valuation of over $100 million and under $1 billion.
  • A reporter who can get behind the scenes and reveal how funding rounds are put together, or why they’ve failed to materialise. She/he in this role will largely focus on long-format stories. 
  • A journalist to track special situations funds, distressed debt and private credit (from the PE angle) across Asia.